van den Berg H - Search Results

1

The TEL-AML1 real-time quantitative polymerase chain reaction (PCR) might replace the antigen receptor-based genomic PCR in clinical minimal residual disease studies in children with acute lymphoblastic leukaemia.

de Haas V, Breunis WB, Dee R, Verhagen OJ, Kroes W, van Wering ER, van Dongen JJ, van den Berg H, van der Schoot CE. de Haas V, et al. Among authors: van dongen jj, van den berg h, van der schoot ce, van wering er. Br J Haematol. 2002 Jan;116(1):87-93. doi: 10.1046/j.1365-2141.2002.03228.x. Br J Haematol. 2002. PMID: 11841400 Free article.

2

Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia.

Steenbergen EJ, Verhagen OJ, van Leeuwen EF, van den Berg H, Behrendt H, Slater RM, von dem Borne AE, van der Schoot CE. Steenbergen EJ, et al. Among authors: van den berg h, van der schoot ce, van leeuwen ef. Leukemia. 1995 Oct;9(10):1726-34. Leukemia. 1995. PMID: 7564517

3

Frequent ongoing T-cell receptor rearrangements in childhood B-precursor acute lymphoblastic leukemia: implications for monitoring minimal residual disease.

Steenbergen EJ, Verhagen OJ, van Leeuwen EF, van den Berg H, von dem Borne AE, van der Schoot CE. Steenbergen EJ, et al. Among authors: van den berg h, van der schoot ce, van leeuwen ef. Blood. 1995 Jul 15;86(2):692-702. Blood. 1995. PMID: 7606000 Free article.

4

IgH/TCR delta PCR oligonucleotide liquid hybridization, a fast and sensitive assay for monitoring minimal residual disease in childhood B-precursor ALL.

Steenbergen EJ, Verhagen OJ, van Leeuwen EF, van den Berg H, Behrendt H, von dem Borne AE, van der Schoot CE. Steenbergen EJ, et al. Among authors: van den berg h, van der schoot ce, van leeuwen ef. Leukemia. 1995 Jan;9(1):216-22. Leukemia. 1995. PMID: 7845021

5

[Children with acute lymphoblastic leukemia: prognostic significance of polymerase-chain-reaction analysis of minimal residual disease].

Steenbergen EJ, Verhagen OJ, van den Berg H, van Leeuwen EF, von dem Borne AE, van der Schoot CE. Steenbergen EJ, et al. Among authors: van den berg h, van der schoot ce, van leeuwen ef. Ned Tijdschr Geneeskd. 1996 Jan 6;140(1):22-8. Ned Tijdschr Geneeskd. 1996. PMID: 8569906 Dutch.

6

Triple immunofluorescence staining for prediction of relapse in childhood precursor B acute lymphoblastic leukaemia.

Vervoordeldonk SF, Merle PA, Behrendt H, Steenbergen EJ, Van Leeuwen EF, Van den Berg H, Von dem Borne AE, Van der Schoot CE, Slaper-Cortenbach IC. Vervoordeldonk SF, et al. Among authors: van den berg h, van der schoot ce, van leeuwen ef. Br J Haematol. 1996 Mar;92(4):922-8. doi: 10.1046/j.1365-2141.1996.440979.x. Br J Haematol. 1996. PMID: 8616086

7

Clonal evolution of immunoglobulin heavy chain rearrangements in childhood B-precursor acute lymphoblastic leukemia after engraftment in SCID mice.

Steenbergen EJ, Verhagen OJ, Nibbering CP, van den Berg H, van Leeuwen EF, Behrendt H, von dem Borne AE, van der Schoot CE. Steenbergen EJ, et al. Among authors: van den berg h, van der schoot ce, van leeuwen ef. Leukemia. 1996 Sep;10(9):1471-8. Leukemia. 1996. PMID: 8751465

8

PCR-positivity in harvested bone marrow predicts relapse after transplantation with autologous purged bone marrow in children in second remission of precursor B-cell acute leukaemia.

Vervoordeldonk SF, Merle PA, Behrendt H, Steenbergen EJ, van den Berg H, van Wering ER, von dem Borne AE, van der Schoot CE, van Leeuwen EF, Slaper-Cortenbach IC. Vervoordeldonk SF, et al. Among authors: van den berg h, van der schoot ce, van wering er, van leeuwen ef. Br J Haematol. 1997 Feb;96(2):395-402. doi: 10.1046/j.1365-2141.1997.d01-2018.x. Br J Haematol. 1997. PMID: 9029032 Free article.

9

Rearrangement status of the malignant cell determines type of secondary IgH rearrangement (V-replacement or V to DJ joining) in childhood B precursor acute lymphoblastic leukemia.

Steenbergen EJ, Verhagen OJ, van den Berg H, van Leeuwen EF, Behrendt H, Slater RR, von dem Borne AE, van der Schoot CE. Steenbergen EJ, et al. Among authors: van den berg h, van der schoot ce, van leeuwen ef. Leukemia. 1997 Aug;11(8):1258-65. doi: 10.1038/sj.leu.2400720. Leukemia. 1997. PMID: 9264379

10

Minimal residual disease studies are beneficial in the follow-up of TEL/AML1 patients with B-precursor acute lymphoblastic leukaemia.

de Haas V, Oosten L, Dee R, Verhagen OJ, Kroes W, van den Berg H, van der Schoot CE. de Haas V, et al. Among authors: van den berg h, van der schoot ce. Br J Haematol. 2000 Dec;111(4):1080-6. doi: 10.1046/j.1365-2141.2000.02434.x. Br J Haematol. 2000. PMID: 11167743 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

795 results

Search Page

Filters